Low-Cost COVID-19 Vaccine May Help the World’s Poorest Countries Fight the Pandemic
Currently in clinical trials in Brazil, Thailand, and Vietnam, a new COVID-19 immunization called NVD-HXP-S may help low- and middle-income countries ensure their residents can get vaccinated against the novel coronavirus. NVD-HXP-S is a molecular-based vaccine that is designed to create strong antibodies to SARS-CoV-2. It can be mass-produced in chicken eggs, similar to the influenza immunization, which reduces cost and increases availability. Data from the first round of clinical trials will be available in July. Click here to read more.